Mitsubishi Tanabe Pharma

Osaka, Japan Founded: 1678 • Age: 348 yrs Acquired By Bain Capital
Innovative therapies and drugs are developed by the pharmaceutical company.

About Mitsubishi Tanabe Pharma

Mitsubishi Tanabe Pharma is a company based in Osaka (Japan) founded in 1678 was acquired by Bain Capital in February 2025.. Mitsubishi Tanabe Pharma has completed 2 acquisitions, including Medicago and NeuroDerm. Mitsubishi Tanabe Pharma operates in a competitive market with competitors including Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others.

  • Headquarter Osaka, Japan
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
    Medicago

    & 1 more

  • Acquired by
    Bain Capital

    (Feb 07, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Mitsubishi Tanabe Pharma
Headcount 5000-10000
Employee Profiles 12
Board Members and Advisors 5
Employee Profiles
People
Kazumasa N.
Chief Transformation Officer & General Counsel
People
David Gan
Vice President
People
Sean William Ryan
Chief Business Officer
People
Yuichi Imura
Principal Research Scientist

Unlock access to complete

Funding Insights of Mitsubishi Tanabe Pharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Mitsubishi Tanabe Pharma

Mitsubishi Tanabe Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Bain Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Debt and equity investments are pursued across multiple sectors.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Mitsubishi Tanabe Pharma

Mitsubishi Tanabe Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Medicago and NeuroDerm. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Parkinson’s disease therapies are developed through proprietary drug reformulations.
2003
Developer of vaccines to treat pandemic and seasonal influenza
1999
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Mitsubishi Tanabe Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Mitsubishi Tanabe Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Mitsubishi Tanabe Pharma

Mitsubishi Tanabe Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Drug discovery and development services for small molecules are provided.
domain founded_year HQ Location
Pharmaceutical products for treating multiple diseases are provided.
domain founded_year HQ Location
Generic drugs and clinical research services are provided globally.
domain founded_year HQ Location
CDMO services for pharma, biotech, and specialty ingredients are provided.
domain founded_year HQ Location
AI powered scientific data management and workflow automation solutions
domain founded_year HQ Location
Laboratory testing, clinical trial research, and biopharma services are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Mitsubishi Tanabe Pharma

Frequently Asked Questions about Mitsubishi Tanabe Pharma

When was Mitsubishi Tanabe Pharma founded?

Mitsubishi Tanabe Pharma was founded in 1678.

Where is Mitsubishi Tanabe Pharma located?

Mitsubishi Tanabe Pharma is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.

Who is the current CEO of Mitsubishi Tanabe Pharma?

Masayuki Mitsuka is the current CEO of Mitsubishi Tanabe Pharma.

What does Mitsubishi Tanabe Pharma do?

Mitsubishi Tanabe Pharma Corporation was founded in 1678 and is headquartered in Osaka, Japan. Operations are focused on the pharmaceutical sector, with research and development centered on innovative therapies. A pipeline of investigational treatments is maintained, and collaborations with other firms are pursued for joint projects. Activities span drug development and therapeutic advancements across global markets.

Who are the top competitors of Mitsubishi Tanabe Pharma?

Mitsubishi Tanabe Pharma's top competitors include Pharmaron, Pfizer and Lonza.

How many acquisitions has Mitsubishi Tanabe Pharma made?

Mitsubishi Tanabe Pharma has made 2 acquisitions, including Medicago, and NeuroDerm.

Who are Mitsubishi Tanabe Pharma's investors?

Mitsubishi Tanabe Pharma has 1 investor. Key investors include Bain Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available